Printer's No. PN1923
See other bills
under the
same topic PRINTER'S NO. 1923 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.365 Session of 2026 INTRODUCED BY BROWN, MARTIN, PHILLIPS-HILL, CULVER, VOGEL, STREET, HAYWOOD, J. WARD AND COSTA, SEPTEMBER 10, 2026 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, SEPTEMBER 10, 2026 A RESOLUTIONRecognizing the month of September 2026 as "Polycystic Kidney Disease Awareness Month" in Pennsylvania.WHEREAS, Polycystic kidney disease (PKD) is a genetic disease that is passed from an affected parent to child and causes uncontrolled growth of cysts in the kidney; andWHEREAS, PKD affects all racial and ethnic groups equally and occurs equally in men and women; andWHEREAS, Approximately 600,000 people in the United States have PKD, and PKD is the fourth leading cause of kidney failure; andWHEREAS, There are two types of PKD: autosomal dominant (ADPKD) and autosomal recessive (ARPKD); andWHEREAS, ADPKD is the most common form of PKD, comprising 90% of all PKD cases, and is passed from parent to child genetically by dominant inheritance; andWHEREAS, Symptoms of ADPKD typically begin between 30 and 40 years of age, but can begin as early as childhood; andWHEREAS, ARPKD is passed from parent to child genetically by 123456789101112131415161718 recessive inheritance; andWHEREAS, ARPKD is a rare form of PKD and occurs in 1 in 20,000 children worldwide; andWHEREAS, Symptoms of ARPKD begin in the earliest months of life, even in the womb; andWHEREAS, ARPKD is very serious because it progresses rapidly and is often fatal in the first few months of life; andWHEREAS, Symptoms that may indicate that an individual has PKD include back or side pain, an increase in the size of the abdomen, blood in the urine, frequent bladder or kidney infections, fluttering or pounding in the chest and high blood pressure; andWHEREAS, High blood pressure is the most common sign of PKD; andWHEREAS, If high blood pressure is treated, the treatment can help slow or even prevent kidney failure; andWHEREAS, Approximately 50% of individuals with PKD have kidney failure by 60 years of age, and 60% of individuals have kidney failure by 70 years of age; andWHEREAS, The only options available for individuals experiencing kidney failure are dialysis or a kidney transplant; andWHEREAS, Although PKD has no cure, supportive treatments can be administered to control symptoms, help slow cyst growth and prevent or slow down the loss of kidney function that results from PKD; andWHEREAS, Supportive treatments for PKD include all of the following:(1) Carefully controlling blood pressure.(2) Promptly treating bladder or kidney infections with 20260SR0365PN1923 - 2 - 123456789101112131415161718192021222324252627282930 antibiotics.(3) Drinking a lot of water when blood in the urine is first noticed.(4) Using medication to control pain.(5) Maintaining a healthy lifestyle by quitting smoking, exercising, controlling weight, avoiding caffeine and reducing salt intake;andWHEREAS, The average annual cost of dialysis treatments is $89,000 per patient, and the total average annual cost of dialysis treatments is $42 billion nationwide; therefore be itRESOLVED, That the Senate recognize the month of September 2026 as "Polycystic Kidney Disease Awareness Month" in Pennsylvania.20260SR0365PN1923 - 3 - 1234567891011121314
under the
same topic PRINTER'S NO. 1923 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.365 Session of 2026 INTRODUCED BY BROWN, MARTIN, PHILLIPS-HILL, CULVER, VOGEL, STREET, HAYWOOD, J. WARD AND COSTA, SEPTEMBER 10, 2026 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, SEPTEMBER 10, 2026 A RESOLUTIONRecognizing the month of September 2026 as "Polycystic Kidney Disease Awareness Month" in Pennsylvania.WHEREAS, Polycystic kidney disease (PKD) is a genetic disease that is passed from an affected parent to child and causes uncontrolled growth of cysts in the kidney; andWHEREAS, PKD affects all racial and ethnic groups equally and occurs equally in men and women; andWHEREAS, Approximately 600,000 people in the United States have PKD, and PKD is the fourth leading cause of kidney failure; andWHEREAS, There are two types of PKD: autosomal dominant (ADPKD) and autosomal recessive (ARPKD); andWHEREAS, ADPKD is the most common form of PKD, comprising 90% of all PKD cases, and is passed from parent to child genetically by dominant inheritance; andWHEREAS, Symptoms of ADPKD typically begin between 30 and 40 years of age, but can begin as early as childhood; andWHEREAS, ARPKD is passed from parent to child genetically by 123456789101112131415161718 recessive inheritance; andWHEREAS, ARPKD is a rare form of PKD and occurs in 1 in 20,000 children worldwide; andWHEREAS, Symptoms of ARPKD begin in the earliest months of life, even in the womb; andWHEREAS, ARPKD is very serious because it progresses rapidly and is often fatal in the first few months of life; andWHEREAS, Symptoms that may indicate that an individual has PKD include back or side pain, an increase in the size of the abdomen, blood in the urine, frequent bladder or kidney infections, fluttering or pounding in the chest and high blood pressure; andWHEREAS, High blood pressure is the most common sign of PKD; andWHEREAS, If high blood pressure is treated, the treatment can help slow or even prevent kidney failure; andWHEREAS, Approximately 50% of individuals with PKD have kidney failure by 60 years of age, and 60% of individuals have kidney failure by 70 years of age; andWHEREAS, The only options available for individuals experiencing kidney failure are dialysis or a kidney transplant; andWHEREAS, Although PKD has no cure, supportive treatments can be administered to control symptoms, help slow cyst growth and prevent or slow down the loss of kidney function that results from PKD; andWHEREAS, Supportive treatments for PKD include all of the following:(1) Carefully controlling blood pressure.(2) Promptly treating bladder or kidney infections with 20260SR0365PN1923 - 2 - 123456789101112131415161718192021222324252627282930 antibiotics.(3) Drinking a lot of water when blood in the urine is first noticed.(4) Using medication to control pain.(5) Maintaining a healthy lifestyle by quitting smoking, exercising, controlling weight, avoiding caffeine and reducing salt intake;andWHEREAS, The average annual cost of dialysis treatments is $89,000 per patient, and the total average annual cost of dialysis treatments is $42 billion nationwide; therefore be itRESOLVED, That the Senate recognize the month of September 2026 as "Polycystic Kidney Disease Awareness Month" in Pennsylvania.20260SR0365PN1923 - 3 - 1234567891011121314
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.